tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2023 Sep 29;10(11)
fad474.
doi: 10.1093/ofid/ofad474. eCollection 2023 Nov. Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022
Palak Patel[SUP] 1 [/SUP], Kristin E Schrader[SUP] 2 [/SUP], Catherine E Rice[SUP] 3 [/SUP], Elizabeth Rowley[SUP] 2 [/SUP], Robyn A Cree[SUP] 3 [/SUP], Malini B DeSilva[SUP] 4 [/SUP], Peter J Embi[SUP] 5 [/SUP], Manjusha Gaglani[SUP] 6 7 [/SUP], Shaun J Grannis[SUP] 8 9 [/SUP], Toan C Ong[SUP] 10 [/SUP], Edward Stenehjem[SUP] 11 [/SUP], Allison L Naleway[SUP] 12 [/SUP], Sarah Ball[SUP] 2 [/SUP], Karthik Natarajan[SUP] 13 14 [/SUP], Nicola P Klein[SUP] 15 [/SUP], Katherine Adams[SUP] 1 [/SUP], Anupam Kharbanda[SUP] 16 [/SUP], Caitlin Ray[SUP] 1 [/SUP], Ruth Link-Gelles[SUP] 17 [/SUP], Mark W Tenforde[SUP] 1 [/SUP]
Affiliations
Adults with disabilities are at increased risk for severe coronavirus disease 2019 (COVID-19). Using data across 9 states during Delta- and Omicron-predominant periods (June 2021-September 2022), we evaluated the effectiveness of the original monovalent COVID-19 messenger RNA vaccines among 521 206 emergency department/urgent care encounters (11 471 [2%] in patients with a documented disability) and 139 548 hospitalizations (16 569 [12%] in patients with a disability) for laboratory-confirmed COVID-19 illness in adults (aged ≥18 years). Across variant periods and for the primary series or booster doses, vaccine effectiveness was similar in those with and those without a disability. These findings highlight the importance of adults with disabilities staying up to date with COVID-19 vaccinations.
Keywords: COVID-19; disabilities; test-negative design; vaccine effectiveness.
. 2023 Sep 29;10(11)
fad474.doi: 10.1093/ofid/ofad474. eCollection 2023 Nov. Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022
Palak Patel[SUP] 1 [/SUP], Kristin E Schrader[SUP] 2 [/SUP], Catherine E Rice[SUP] 3 [/SUP], Elizabeth Rowley[SUP] 2 [/SUP], Robyn A Cree[SUP] 3 [/SUP], Malini B DeSilva[SUP] 4 [/SUP], Peter J Embi[SUP] 5 [/SUP], Manjusha Gaglani[SUP] 6 7 [/SUP], Shaun J Grannis[SUP] 8 9 [/SUP], Toan C Ong[SUP] 10 [/SUP], Edward Stenehjem[SUP] 11 [/SUP], Allison L Naleway[SUP] 12 [/SUP], Sarah Ball[SUP] 2 [/SUP], Karthik Natarajan[SUP] 13 14 [/SUP], Nicola P Klein[SUP] 15 [/SUP], Katherine Adams[SUP] 1 [/SUP], Anupam Kharbanda[SUP] 16 [/SUP], Caitlin Ray[SUP] 1 [/SUP], Ruth Link-Gelles[SUP] 17 [/SUP], Mark W Tenforde[SUP] 1 [/SUP]
Affiliations
- PMID: 37965644
- PMCID: PMC10642729
- DOI: 10.1093/ofid/ofad474
Adults with disabilities are at increased risk for severe coronavirus disease 2019 (COVID-19). Using data across 9 states during Delta- and Omicron-predominant periods (June 2021-September 2022), we evaluated the effectiveness of the original monovalent COVID-19 messenger RNA vaccines among 521 206 emergency department/urgent care encounters (11 471 [2%] in patients with a documented disability) and 139 548 hospitalizations (16 569 [12%] in patients with a disability) for laboratory-confirmed COVID-19 illness in adults (aged ≥18 years). Across variant periods and for the primary series or booster doses, vaccine effectiveness was similar in those with and those without a disability. These findings highlight the importance of adults with disabilities staying up to date with COVID-19 vaccinations.
Keywords: COVID-19; disabilities; test-negative design; vaccine effectiveness.